Literature DB >> 16557298

Induction of myasthenia by immunization against muscle-specific kinase.

Kazuhiro Shigemoto1, Sachiho Kubo, Naoki Maruyama, Naohito Hato, Hiroyuki Yamada, Chen Jie, Naoto Kobayashi, Katsumi Mominoki, Yasuhito Abe, Norifumi Ueda, Seiji Matsuda.   

Abstract

Muscle-specific kinase (MuSK) is critical for the synaptic clustering of nicotinic acetylcholine receptors (AChRs) and plays multiple roles in the organization and maintenance of neuromuscular junctions (NMJs). MuSK is activated by agrin, which is released from motoneurons, and induces AChR clustering at the postsynaptic membrane. Although autoantibodies against the ectodomain of MuSK have been found in a proportion of patients with generalized myasthenia gravis (MG), it is unclear whether MuSK autoantibodies are the causative agent of generalized MG. In the present study, rabbits immunized with MuSK ectodomain protein manifested MG-like muscle weakness with a reduction of AChR clustering at the NMJs. The autoantibodies activated MuSK and blocked AChR clustering induced by agrin or by mediators that do not activate MuSK. Thus MuSK autoantibodies rigorously inhibit AChR clustering mediated by multiple pathways, an outcome that broadens our general comprehension of the pathogenesis of MG.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16557298      PMCID: PMC1409737          DOI: 10.1172/JCI21545

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  50 in total

1.  Distinct roles of nerve and muscle in postsynaptic differentiation of the neuromuscular synapse.

Authors:  W Lin; R W Burgess; B Dominguez; S L Pfaff; J R Sanes; K F Lee
Journal:  Nature       Date:  2001-04-26       Impact factor: 49.962

2.  Acetylcholine receptors are required for agrin-induced clustering of postsynaptic proteins.

Authors:  P A Marangi; J R Forsayeth; P Mittaud; S Erb-Vögtli; D J Blake; M Moransard; A Sander; C Fuhrer
Journal:  EMBO J       Date:  2001-12-17       Impact factor: 11.598

3.  Patterning of muscle acetylcholine receptor gene expression in the absence of motor innervation.

Authors:  X Yang; S Arber; C William; L Li; Y Tanabe; T M Jessell; C Birchmeier; S J Burden
Journal:  Neuron       Date:  2001-05       Impact factor: 17.173

4.  Agrin-induced activation of acetylcholine receptor-bound Src family kinases requires Rapsyn and correlates with acetylcholine receptor clustering.

Authors:  P Mittaud; P A Marangi; S Erb-Vögtli; C Fuhrer
Journal:  J Biol Chem       Date:  2001-01-31       Impact factor: 5.157

5.  MuSK Ab described in seropositive MG sera found to be Ab to alkaline phosphatase.

Authors:  K Ohta; K Shigemoto; S Kubo; N Maruyama; Y Abe; N Ueda; A Fujinami; M Ohta
Journal:  Neurology       Date:  2005-12-27       Impact factor: 9.910

6.  Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.

Authors:  W Hoch; J McConville; S Helms; J Newsom-Davis; A Melms; A Vincent
Journal:  Nat Med       Date:  2001-03       Impact factor: 53.440

7.  Differential Vicia villosa agglutinin reactivity identifies three distinct dystroglycan complexes in skeletal muscle.

Authors:  E L McDearmon; A C Combs; J M Ervasti
Journal:  J Biol Chem       Date:  2001-07-17       Impact factor: 5.157

8.  Cloning and characterization of muscle-specific kinase in chicken.

Authors:  F C Ip; D G Glass; D R Gies; J Cheung; K O Lai; A K Fu; G D Yancopoulos; N Y Ip
Journal:  Mol Cell Neurosci       Date:  2000-11       Impact factor: 4.314

9.  MuSK glycosylation restrains MuSK activation and acetylcholine receptor clustering.

Authors:  Anke Watty; Steven J Burden
Journal:  J Biol Chem       Date:  2002-10-23       Impact factor: 5.157

10.  Laminin-1 redistributes postsynaptic proteins and requires rapsyn, tyrosine phosphorylation, and Src and Fyn to stably cluster acetylcholine receptors.

Authors:  P Angelo Marangi; Simon T Wieland; Christian Fuhrer
Journal:  J Cell Biol       Date:  2002-05-28       Impact factor: 10.539

View more
  38 in total

1.  Effect of complement and its regulation on myasthenia gravis pathogenesis.

Authors:  Linda L Kusner; Henry J Kaminski; Jindrich Soltys
Journal:  Expert Rev Clin Immunol       Date:  2008-01       Impact factor: 4.473

2.  Antibodies against low-density lipoprotein receptor-related protein 4 induce myasthenia gravis.

Authors:  Chengyong Shen; Yisheng Lu; Bin Zhang; Dwight Figueiredo; Jonathan Bean; Jiung Jung; Haitao Wu; Arnab Barik; Dong-Min Yin; Wen-Cheng Xiong; Lin Mei
Journal:  J Clin Invest       Date:  2013-11-08       Impact factor: 14.808

Review 3.  Practical Anatomy of the Neuromuscular Junction in Health and Disease.

Authors:  Hiroshi Nishimune; Kazuhiro Shigemoto
Journal:  Neurol Clin       Date:  2018-05       Impact factor: 3.806

4.  Anti-MuSK autoantibodies block binding of collagen Q to MuSK.

Authors:  Y Kawakami; M Ito; M Hirayama; K Sahashi; B Ohkawara; A Masuda; H Nishida; N Mabuchi; A G Engel; K Ohno
Journal:  Neurology       Date:  2011-10-19       Impact factor: 9.910

Review 5.  The neonatal Fc receptor as therapeutic target in IgG-mediated autoimmune diseases.

Authors:  Alina Sesarman; Gestur Vidarsson; Cassian Sitaru
Journal:  Cell Mol Life Sci       Date:  2010-03-09       Impact factor: 9.261

6.  Animal models of antimuscle-specific kinase myasthenia.

Authors:  David P Richman; Kayoko Nishi; Michael J Ferns; Joachim Schnier; Peter Pytel; Ricardo A Maselli; Mark A Agius
Journal:  Ann N Y Acad Sci       Date:  2012-12       Impact factor: 5.691

Review 7.  The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis.

Authors:  Inga Koneczny; Judith Cossins; Angela Vincent
Journal:  J Anat       Date:  2013-03-04       Impact factor: 2.610

8.  MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4.

Authors:  Maartje G Huijbers; Wei Zhang; Rinse Klooster; Erik H Niks; Matthew B Friese; Kirsten R Straasheijm; Peter E Thijssen; Hans Vrolijk; Jaap J Plomp; Pauline Vogels; Mario Losen; Silvère M Van der Maarel; Steven J Burden; Jan J Verschuuren
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

9.  Pyridostigmine but not 3,4-diaminopyridine exacerbates ACh receptor loss and myasthenia induced in mice by muscle-specific kinase autoantibody.

Authors:  Marco Morsch; Stephen W Reddel; Nazanin Ghazanfari; Klaus V Toyka; William D Phillips
Journal:  J Physiol       Date:  2013-02-25       Impact factor: 5.182

10.  Muscle-specific receptor tyrosine kinase antibody positive myasthenia gravis current status.

Authors:  Shin Joong Oh
Journal:  J Clin Neurol       Date:  2009-06-30       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.